Your browser doesn't support javascript.
loading
First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19.
Tantry, Udaya S; Bliden, Kevin P; Cho, Alastair; Walia, Naval; Dahlen, Jeffrey R; Ens, Gordon; Traianova, Malina; Jerjian, Christophe; Usman, Abira; Gurbel, Paul A.
Afiliação
  • Tantry US; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA.
  • Bliden KP; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA.
  • Cho A; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA.
  • Walia N; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA.
  • Dahlen JR; Hikari Dx, Inc, San Diego, California, USA.
  • Ens G; Inflammatory Markers Laboratory, Wichita, Kansas, USA.
  • Traianova M; CEDx Laboratory, Nashua, New Hampshire, USA.
  • Jerjian C; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA.
  • Usman A; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA.
  • Gurbel PA; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA.
Open Forum Infect Dis ; 8(7): ofab274, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34250193
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article